PRISM Registry: Pseudobulbar Affect Registry Series

Clinical trial NCT01366027 · COMPLETED

Trial details

NCT number: NCT01366027
Sponsor: Avanir Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Alzheimer's Disease Amyotrophic Lateral Sclerosis (ALS)Multiple Sclerosis (MS)Parkinson's Disease Stroke Traumatic Brain Injury

Start date: 2011-05-01
Primary completion: 2012-09-01
Enrollment: 5290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.